ARTICLE | Distillery Therapeutics
Cancer
February 6, 2018 5:02 PM UTC
Patient sample and mouse studies suggest promoting IGFBP3 expression could help treat MYCN-driven neuroblastoma. In five MYCN-driven neuroblastoma cell lines, IGFBP3 encoded by a plasmid vector decrea...